[Cytostatic treatment of nonmalignant diseases].
D000470:Alkaloids / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy
D000470:Alkaloids; D000477:Alkylating Agents; D000903:Antibiotics, Antineoplastic; D000963:Antimetabolites; D000970:Antineoplastic Agents; D006834:Hydrazines; D007166:Immunosuppressive Agents
Cytostatische Behandlung nicht maligner Erkrankungen.